143 related articles for article (PubMed ID: 33883507)
21. Post-heart transplantation outcome of HeartMate II-bridged recipients requiring unplanned concomitant temporary right ventricular mechanical support.
Urban M; Pirk J; Szarszoi O; Besik J; Netuka I
Interact Cardiovasc Thorac Surg; 2015 Mar; 20(3):372-8. PubMed ID: 25487235
[TBL] [Abstract][Full Text] [Related]
22. Device exchange from HeartMate II to HeartMate 3 left ventricular assist device.
Takeda K; Takayama H; Sanchez J; Cevasco M; Yuzefpolskaya M; Colombo PC; Naka Y
Interact Cardiovasc Thorac Surg; 2019 Sep; 29(3):430-433. PubMed ID: 31143932
[TBL] [Abstract][Full Text] [Related]
23. The association of pretransplant HeartMate II left ventricular assist device placement and heart transplantation mortality.
Donneyong M; Cheng A; Trivedi JR; Schumer E; McCants KC; Birks EJ; Slaughter MS
ASAIO J; 2014; 60(3):294-9. PubMed ID: 24614355
[TBL] [Abstract][Full Text] [Related]
24. Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort.
Arnaoutakis GJ; George TJ; Kilic A; Weiss ES; Russell SD; Conte JV; Shah AS
J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1236-45, 1245.e1. PubMed ID: 21839482
[TBL] [Abstract][Full Text] [Related]
25. Association of device surface and biomaterials with immunologic sensitization after mechanical support.
George I; Colley P; Russo MJ; Martens TP; Burke E; Oz MC; Deng MC; Mancini DM; Naka Y
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1372-9. PubMed ID: 18544389
[TBL] [Abstract][Full Text] [Related]
26. Pressure-dimension index and left ventricular sphericity index following HeartMate II and HeartMate 3 implantation.
Schnoering L; Khattab MA; Akhyari P; Moza A; Haneya A; Diab AH; Abugameh A; Lotfi S; Zayat R
ESC Heart Fail; 2024 Jun; ():. PubMed ID: 38840435
[TBL] [Abstract][Full Text] [Related]
27. Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial.
Patel CB; Blue L; Cagliostro B; Bailey SH; Entwistle JW; John R; Thohan V; Cleveland JC; Goldstein DJ; Uriel N; Su X; Somo SI; Sood P; Mehra MR
J Heart Lung Transplant; 2020 Aug; 39(8):774-781. PubMed ID: 32276809
[TBL] [Abstract][Full Text] [Related]
28. Emerging electromagnetic interferences between implantable cardioverter-defibrillators and left ventricular assist devices.
Yalcin YC; Kooij C; Theuns DAMJ; Constantinescu AA; Brugts JJ; Manintveld OC; Yap SC; Szili-Torok T; Bogers AJJC; Caliskan K
Europace; 2020 Apr; 22(4):584-587. PubMed ID: 32003803
[TBL] [Abstract][Full Text] [Related]
29. HVAD versus heartmate III bridge to heart transplantation: Waitlist and posttransplant outcomes.
Hess NR; Witer L; Katz MR; Pope NH; Tedford RJ; Houston BA; Kilic A
Clin Transplant; 2022 Mar; 36(3):e14546. PubMed ID: 34843123
[TBL] [Abstract][Full Text] [Related]
30. Concurrent valvular procedures during left ventricular assist device implantation and outcomes: A comprehensive analysis of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 trial portfolio.
John R; Kanwar MK; Cleveland JC; Uriel N; Naka Y; Salerno C; Horstmanshof D; Hall SA; Cowger JA; Heatley G; Somo SI; Mehra MR
J Thorac Cardiovasc Surg; 2023 Dec; 166(6):1684-1694.e18. PubMed ID: 35643769
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of modular cable exchange in HeartMate 3 patients versus conventional driveline repair in HeartMate II patients.
Merzah AS; Hanke JS; Li T; Saad Merzah FA; Gabriel M; Derda AA; Homann K; Haverich A; Schmitto JD; Dogan G
Artif Organs; 2023 Feb; 47(2):380-386. PubMed ID: 36148849
[TBL] [Abstract][Full Text] [Related]
32. Five-year results of patients supported by HeartMate II: outcomes and adverse events.
Hanke JS; Rojas SV; Mahr C; Schmidt AF; Zoch A; Dogan G; Feldmann C; Deniz E; Molitoris U; Bara C; Strüber M; Haverich A; Schmitto JD
Eur J Cardiothorac Surg; 2018 Feb; 53(2):422-427. PubMed ID: 28958073
[TBL] [Abstract][Full Text] [Related]
33. Cerebral vasoreactivity in HeartMate 3 patients.
Stöhr EJ; Ji R; Akiyama K; Mondellini G; Braghieri L; Pinsino A; Cockcroft JR; Yuzefpolskaya M; Amlani A; Topkara VK; Takayama H; Naka Y; Uriel N; Takeda K; Colombo PC; McDonnell BJ; Willey JZ
J Heart Lung Transplant; 2021 Aug; 40(8):786-793. PubMed ID: 34134913
[TBL] [Abstract][Full Text] [Related]
34. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
35. Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients.
Drakos SG; Kfoury AG; Long JW; Stringham JC; Fuller TC; Nelson KE; Campbell BK; Gilbert EM; Renlund DG
Ann Thorac Surg; 2006 Sep; 82(3):889-93. PubMed ID: 16928502
[TBL] [Abstract][Full Text] [Related]
36. Left ventricular assist device driveline infections in three contemporary devices.
Schlöglhofer T; Michalovics P; Riebandt J; Angleitner P; Stoiber M; Laufer G; Schima H; Wiedemann D; Zimpfer D; Moscato F
Artif Organs; 2021 May; 45(5):464-472. PubMed ID: 33052592
[TBL] [Abstract][Full Text] [Related]
37. An 18-month comparison of clinical outcomes between continuous-flow left ventricular assist devices.
Itzhaki Ben Zadok O; Ben-Avraham B; Shaul A; Hammer Y; Rubachevski V; Aravot D; Kornowski R; Ben-Gal T
Eur J Cardiothorac Surg; 2019 Dec; 56(6):1054-1061. PubMed ID: 31566245
[TBL] [Abstract][Full Text] [Related]
38. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
39. Utility of cardiac computed tomography for inflow cannula patency assessment and prediction of clinical outcome in patients with the HeartMate II left ventricular assist device.
Sacks J; Gonzalez-Stawinski GV; Hall S; Lima B; MacHannaford J; Dockery W; Cura M; Chamogeorgakis T
Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):590-3. PubMed ID: 26223857
[TBL] [Abstract][Full Text] [Related]
40. HeartWare and HeartMate II left ventricular assist devices as bridge to transplantation: a comparative analysis.
Topkara VK; O'Neill JK; Carlisle A; Novak E; Silvestry SC; Ewald GA
Ann Thorac Surg; 2014 Feb; 97(2):506-12. PubMed ID: 24140211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
